Yes, there’s a market for LL in HIV. “In f
Post# of 148182
“In fact, according to one report, 50% of HIV patients are now multidrug resistant.”
Patients will, over time, continue to become multi drug resistant. It’s a continuum, not a snapshot, and continues to be an unmet need IMO.
Read More: https://investorshangout.com/post/view?id=641...z7W1aoVyo2